Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 3 (2007), Issue 1 (January)

1. Economics of new oncology drug development.
   J Clin Oncol, 25(2): 209-16. [Abstract] [Full-text]
2. Chemically engineered extracts as an alternative source of bioactive natural product-like compounds.
   Proc Natl Acad Sci U S A, 104(2): 441-4. [Abstract] [Full-text]
3. Particle size analysis in pharmaceutics: principles, methods and applications.
   Pharm Res, 24(2): 203-27. [Abstract] [Full-text]
4. QSPR model of Henry's law constant for a diverse set of organic chemicals based on genetic algorithm-radial basis function network approach.
   Chemosphere, 66(11): 2067-76. [Abstract] [Full-text]
5. What's next in translational medicine?
   Clin Sci (Lond), 112(4): 217-27. [Abstract] [Full-text]
6. Design and characterization of a platelet-targeted plasminogen activator with enhanced thrombolytic and antithrombotic potency.
   Biotechnol Appl Biochem, 46: 115-25. [Abstract] [Full-text]
7. Stereoselectivity by enantiomeric inhibitors of matrix metalloproteinase-8: new insights from molecular dynamics simulations.
   J Med Chem, 50(2): 211-8. [Abstract] [Full-text]
8. Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine.
   Transl Res, 149(2): 55-61. [Abstract] [Full-text]
9. EUROTOX's view regarding the ROLE and TRAINING of certified European registered toxicologists (ERT).
   Toxicol Lett, 168(3): 192-9. [Abstract] [Full-text]
10. A review of human vaccine research and development: malaria.
    Vaccine, 25(9): 1567-80. [Abstract] [Full-text]
11. Biocatalysis for pharmaceutical intermediates: the future is now.
    Trends Biotechnol, 25(2): 66-73. [Abstract] [Full-text]
12. Compressing drug development timelines in oncology using phase '0' trials.
    Nat Rev Cancer, 7(2): 131-9. [Abstract] [Full-text]
13. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Biochim Biophys Acta, 1770(3): 489-94. [Abstract] [Full-text]
14. Chiral imine copper chloride-catalyzed enantioselective desymmetrization of 2-substituted 1,2,3-propanetriols.
    Proc Natl Acad Sci U S A, 104(5): 1471-5. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.